Boston Sci Q4 top line up 10%; non-GAAP earning up 14% [Seeking Alpha]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Seeking Alpha
Boston Sci Q4 top line up 10%; non-GAAP earning up 14%Boston Scientific (NYSE:BSX)Q4 results ($M): Revenues: 2,408 (+9.9%); Interventional Cardiology: 636 (+8.7%); Peripheral Interventions: 277 (+8.6%); Cardiovascular: 913 (+8.7%); Cardiac Rhythm Management: 488 (+3.2%); Electrophysiology: 77 (+22.2%); Rhythm Management: 565 (+5.4%); Endoscopy: 436 (+14.7%); Urology & Pelvic Health: 308 (+12.4%); Neuromodulation: 186 (+15.5%); MedSurg: 931 (+14.2%).Net loss: (615) (-596.0%); non-GAAP net income: 530 (+13.5%); loss/share: (0.45) (-600.0%); non-GAAP EPS: 0.34 (+13.3%).GAAP earnings were negatively impacted by a one-time income tax charge from the Tax Cuts and Jobs Act.2018 Guidance: Revenues: $9.65B - 9.80B (+7 - 8%); EPS: $0.93 - 0.98; non-GAAP EPS: $1.35 - 1.39.Q1 Guidance: Revenues: $2.32B - 2.35B (+7 - 9%); EPS: $0.19 - 0.22; non-GAAP EPS: $0.30 - 0.32.Shares are down1% premarket.See all stocks on the move »Now read:Integra LifeSciences Holdings (IART) Presents At 36th Annual J.P. M
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Citigroup Inc. from $79.00 to $85.00. They now have a "buy" rating on the stock.MarketBeat
- Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at JPMorgan Chase & Co. from $72.00 to $82.00. They now have an "overweight" rating on the stock.MarketBeat
- Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $63.00 to $73.00. They now have a "hold" rating on the stock.MarketBeat
- Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Royal Bank of Canada from $78.00 to $82.00. They now have an "outperform" rating on the stock.MarketBeat
- Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Raymond James from $73.00 to $85.00. They now have a "strong-buy" rating on the stock.MarketBeat
BSX
Earnings
- 4/24/24 - Miss
BSX
Sec Filings
- 4/24/24 - Form 8-K
- 4/4/24 - Form 8-K
- 4/2/24 - Form 4
- BSX's page on the SEC website